70370-1040 : Ingrezza 40 mg Oral Capsule


NDC70370-1040
Labeler: Neurocrine Biosciences, Inc.
Product Type: Human Prescription Drug
Drug Name:  Ingrezza
Dosage Form: Oral Capsule
Application #: NDA209241
Rev. Date: 


Appearance:


Markings: VBZ;40
Shapes:  Capsule
Colors:  White / Purple
Size (mm): 19
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 70370-1040-1: 30 CAPSULE IN 1 BOTTLE (70370‑1040‑1)
  • 70370-1040-2: 90 CAPSULE IN 1 BOTTLE (70370‑1040‑2)

Active Ingredients:

  • Valbenazine

Dosage Strength:

  • 40 mg

Inactive Ingredients:

  • Mannitol
  • Starch, Pregelatinized Corn
  • Silicon Dioxide
  • Magnesium Stearate
  • Gelatin
  • Fd&c Red No. 40
  • Fd&c Blue No. 1

Pharmaceutical Classes:

  • Vesicular Monoamine Transporter 2 Inhibitor [EPC]
  • Vesicular Monoamine Transporter 2 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 70370-1048 Ingrezza Oral Kit by Neurocrine Biosciences, Inc.
  • 70370-1080 Ingrezza 80 mg Oral Capsule by Neurocrine Biosciences, Inc.
  • 70370-2040 Ingrezza 40 mg Oral Capsule by Neurocrine Biosciences, Inc.
  • 70370-2048 IngrezzaIngrezza Oral Kit by Neurocrine Biosciences, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70370-1040 QR Code

< Prev: 70369-007Next: 70370-1048 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 February 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA